|
|
-
May 02,2012
Entia Biosciences Launches Medical Food for Treatment of Rheumatoid Arthritis
Entia Biosciences, Inc has developed a new medical food for the treatment of Rheumatoid Arthritis (RA), a systemic autoimmune disease that causes pain, stiffness, swelling, and loss of function in the joints. -
Feb 24,2012
Entia Biosciences Developing ErgoD2™ line of Medical Foods
Entia is developing a line of medical food products based on its proprietary ErgoD2™ whole-food formulations. ErgoD2™ is a 100% vegan and USDA certified organic formulation from mushrooms that have been enhanced with the Company’s patent pending UV light technology and contain naturally high concentrations of the powerful antioxidants Ergothioneine and Ergocalciferol (vitamin D2).
-
Feb 01,2012
ErgoD2 Achieves Important Safety Milestone for Entia Biosciences
ENTIA announced today that it has successfully completed an acute oral toxicity study (LD50) with its proprietary ErgoD2™ whole‐food formulation. -
Jan 11,2012
Dr. Paul Vanhoutte to Serve as Co-chairman of Entia’s Scientific Advisory Board
Dr. Paul M. Vanhoutte MD, Ph.D., the internationally respected cardiologist and research scientist, has agreed to serve as Co-chairman of the Company’s recently formed Scientific Advisory Board (SAB).
-
Jan 05,2012
Patent Filed on L-Ergothioneine Discovery in Hair and Nail Growth
TNS announced today that it has filed a provisional patent entitled: “A Nutritional Approach to the Use of Ergothioneine for Hair and Nail Growth.” The patent covers the use of ingestible and topically applied natural and/or synthetic L-Ergothioneine (Ergo) to maintain and improve hair and nail health, growth, and natural coloring.
